Re-irradiation of metastatic disease in the neck from xeroderma pigmentosum
- PMID: 20567629
- PMCID: PMC2880910
- DOI: 10.3747/co.v17i3.479
Re-irradiation of metastatic disease in the neck from xeroderma pigmentosum
Abstract
Background: Xeroderma pigmentosum, an autosomal recessive disease that occurs with a frequency of 1:250,000, is caused by a genetic defect in nucleotide excision repair enzymes. Mutation of these enzymes leads to the development of multiple basal cell and squamous cell carcinomas.
Objectives: We present a case of xeroderma pigmentosum in a patient with cervical and intraparotid metastatic disease from recurrent cutaneous squamous cell carcinomas of the face and scalp, treated with neck dissection and re-irradiation. With the illustrative case report, we include a literature review of diagnosis, prognostic factors, and treatment, with emphasis on surgical and radiation treatment of cervical metastatic disease from recurrent skin carcinomas.
Case presentation: A xeroderma pigmentosum patient presented to our clinic with a 2-cm right submental and 1-cm right infra-auricular mass after resection of multiple squamous cell carcinomas of the scalp and face, and external-beam radiation therapy to the right face and neck. Fine-needle aspiration biopsy of the submental mass revealed poorly differentiated squamous cell carcinoma. The patient was brought to the operating room for a right modified radical neck dissection and excision of the right submental and intraparotid mass. Surgical pathology revealed 3 level ia and supraclavicular lymph nodes that were positive for metastatic squamous cell carcinoma. Re-irradiation to the entire right hemi-neck and left submandibular nodal region was performed using opposed oblique portals for the upper neck and a low anterior en face hemi-neck portal. The left parotid region was also included in the re-irradiation volume. Treatment was completed without delayed complications or recurrences to date.
Conclusions: To our knowledge, this is the first case report in the literature of a patient with xeroderma pigmentosum who subsequently developed metastatic disease from recurrent cutaneous squamous cell carcinoma. Because of the rarity of xeroderma pigmentosum, this case report is also the first to describe re-irradiation to treat cervical and intraparotid metastatic disease in a xeroderma pigmentosum patient.
Keywords: Xeroderma pigmentosum; head-and-neck cancer; radiation; re-irradiation.
Similar articles
-
Recurrent squamous cell carcinoma and a novel mutation in a patient with xeroderma pigmentosum: a case report.J Med Case Rep. 2022 Jul 28;16(1):306. doi: 10.1186/s13256-022-03524-2. J Med Case Rep. 2022. PMID: 35902966 Free PMC article.
-
Scalp squamous cell carcinoma in xeroderma pigmentosum.N Am J Med Sci. 2014 Feb;6(2):105-6. doi: 10.4103/1947-2714.127754. N Am J Med Sci. 2014. PMID: 24695441 Free PMC article.
-
Cutaneous malignancies in xeroderma pigmentosum: earlier management improves survival.Indian J Otolaryngol Head Neck Surg. 2013 Apr;65(2):162-7. doi: 10.1007/s12070-012-0614-6. Epub 2013 Jan 5. Indian J Otolaryngol Head Neck Surg. 2013. PMID: 24427558 Free PMC article.
-
Xeroderma pigmentosum in Ghanaians: a report of three cases and review of literature.West Afr J Med. 2014 Jan-Mar;33(1):82-5. West Afr J Med. 2014. PMID: 24872274 Review. English, French.
-
Xeroderma pigmentosum: a case report and review of the literature.J Prev Med Hyg. 2010 Jun;51(2):87-91. J Prev Med Hyg. 2010. PMID: 21155411 Review.
Cited by
-
Therapeutics of xeroderma pigmentosum: A PRISMA-compliant systematic review.Indian J Dermatol Venereol Leprol. 2021 Mar-Apr;87(2):176-189. doi: 10.25259/IJDVL_431_19. Indian J Dermatol Venereol Leprol. 2021. PMID: 33769755
-
Unresectable and chemoresistant conjunctival squamous cell carcinoma on xeroderma pigmentosum treated by salvage radiation therapy: A case report and a review of the literature.Clin Case Rep. 2022 Sep 24;10(9):e6360. doi: 10.1002/ccr3.6360. eCollection 2022 Sep. Clin Case Rep. 2022. PMID: 36188050 Free PMC article.
-
Mutations in Cockayne Syndrome-Associated Genes (Csa and Csb) Predispose to Cisplatin-Induced Hearing Loss in Mice.J Neurosci. 2016 Apr 27;36(17):4758-70. doi: 10.1523/JNEUROSCI.3890-15.2016. J Neurosci. 2016. PMID: 27122034 Free PMC article.
References
-
- Daya–Grosjean L. Xeroderma pigmentosum and skin cancer. Adv Exp Med Biol. 2008;637:19–27. - PubMed
-
- Rubio Casadevall J, Grana–Suarez B, Hernandez–Yague X. Xeroderma pigmentosum: neck lymph node metastasis of a squamous cell carcinoma of the skin treated with cetuximab. Eur J Dermatol. 2009;19:163–5. - PubMed
-
- Rogers PB, Plowman PN, Harris SJ, Arlett CF. Four radiation hypersensitivity cases and their implications for clinical radiotherapy. Radiother Oncol. 2000;57:143–54. - PubMed
-
- Arlett CF, Plowman PN, Rogers PB, et al. Clinical and cellular ionizing radiation sensitivity in a patient with xeroderma pigmentosum. Br J Radiol. 2006;79:510–17. - PubMed
-
- DiGiovanna JJ, Patronas N, Katz D, Abangan D, Kraemer KH. Xeroderma pigmentosum: spinal cord astrocytoma with 9-year survival after radiation and isotretinoin therapy. J Cutan Med Surg. 1998;2:153–8. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials